Prostate Cancer Foundation Announces University of Michigan Researchers Discover Melanoma Drug Target That Occurs in Prostate Cancer Patients

ANN ARBOR, Mich.--(BUSINESS WIRE)--The Prostate Cancer Foundation announced today that researchers at the University of Michigan Comprehensive Cancer Center have discovered the RAF oncogene that drives fatal melanomas may also drive the aggressive forms of prostate cancer in the clinic.

Back to news